Trial intelligence / Profile preview

HRVB-SCT for Smoking Cessation

NCT05224050Phase 2Completed

Sponsor
Rutgers University
Start
Nov 2021
Primary completion
Jun 2023
Countries
1
01

Overview

Phase 2, open-label, single-arm trial, sponsored by Rutgers University. Primary endpoints: Intervention Feasibility: Participant Attendance at 6 weeks, Intervention Feasibility: Participant Practice Adherence at 6 weeks and 5 more. Started Nov 2021; status: completed.

Beyond the preview

Go deeper on NCT05224050.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05224050.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call